Structure and Expression of the Human GATA3 Gene

doi:10.1006/geno.1994.1217

Genomics

Volume 21, Issue 1, 1 May 1994, Pages 1-6

https://doi.org/10.1006/geno.1994.1217 Get rights and content

Abstract

GATA3, a member of the GATA family that is abundantly expressed in the T-lymphocyte lineage, is thought to participate in T-cell receptor gene activation through binding to enhancers. To understand GATA3 gene regulation, we cloned the human gene and the 5′ end of the mouse GATA3 gene. We show that the human GATA3 gene contains six exons distributed over 17 kb of DNA. The two human GATA3 zinc fingers are encoded by two separate exons highly conserved with those of GATA1, but no other structural homologies between these two genes can be found. The human and mouse GATA3 transcription units start at a major initiation site. The promoter sequence analysis of these two genes revealed that they are embedded within a CpG island and share structural features often found in the promoters of housekeeping genes. Finally, we show that a DNA fragment containing the human GATA3 transcription unit, 3 kb upstream from the initiation site and 4 kb downstream from the polyadenylation site, displays T-cell specificity.

References (0)

Cited by (54)

A novel GATA3 frameshift mutation causes hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome
2024, Molecular Genetics and Metabolism Reports
Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome (Barakat syndrome) is a rare autosomal dominant disorder caused by mutations in the gene encoding GATA3 on chromosome 10p14.
Informed consent was obtained from a 38-year-old female patient. 5 mL of venous blood was collected and sent for whole-exome sequencing. GATA3 constructs of both wild-type and mutant were transfected into HEK-293 T cells. Three-dimensional modeling, luciferase-reporter gene test, western blotting and cellular immunofluorescence were used to evaluate the effect of the mutation.
A novel frameshift mutation c. 677dup(p.Pro227AlafsTer77), named P227Afs, was found in GATA3. Three-dimensional modeling revealed that the mutation caused the loss of the dual zinc finger structures 1 and 2 (ZNF1 and ZNF2) of the synthesized protein. Expression of wild-type GATA3 produced a six-fold increase in luciferase activity when compared with pcDNA3.1 vector only (P < 0.001), whereas the P227Afs mutant showed no increase. The mutation significantly reduced the transcriptional activity of GATA3. Immunofluorescence and western blotting analyses demonstrated that the mutation changed the nuclear location of GATA3 and caused difficulty in nuclearization.
A novel heterozygous frameshift mutation in GATA3 was identified and showed to result in difficult nuclearization, and a dominant-negative effect on the wild-type.
Mechanistic insights into the protective impact of zinc on sepsis
2018, Cytokine and Growth Factor Reviews
Citation Excerpt :
Many transcription factors depend on zinc-finger structures for proper protein–protein interaction and/or DNA binding. GATA3 for example contains two (Cys)4 zinc fingers which are essential for GATA3 DNA binding, and which therefore help to determining T-cell lineage differentiation and activity [30–32]. The PPAR transcription factors, which bind lipid-like ligands, undergo hetero-dimerization with other proteins, such as the RXR, via their zinc-fingers [33].
Sepsis, a systemic inflammation as a response to a bacterial infection, is a huge unmet medical need. Data accumulated over the last decade suggest that the nutritional status of patients as well as composition of their gut microbiome, are strongly linked with the risk to develop sepsis, the severity of the disease and prognosis. In particular, the essential micronutrient zinc is essential in the resistance against sepsis and has shown to be protective in animal models as well as in human patients. The potential mechanisms by which zinc protects in sepsis are discussed in this review paper: we will focus on the inflammatory response, chemotaxis, phagocytosis, immune response, oxidative stress and modulation of the microbiome. A full understanding of the mechanism of action of zinc may open new preventive and therapeutic interventions in sepsis.
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
2016, Cancer Letters
Citation Excerpt :
In the neoadjuvant setting both GATA3 mRNA and GATA3 protein expression were shown to be predictive of a favorable response to chemotherapy [17,23]. The human GATA3 gene is a highly conserved gene located at 10p14-15 and consists of six exons which encode a protein of 444 residues [24]. Germline mutations of GATA3 cause a rare and complex disease of hypoparathyroidism, sensorineural deafness and renal insufficiency (HDR syndrome) [25].
In breast cancer, GATA3 mutations have been associated with a favorable prognosis and the response to neoadjuvant aromatase inhibitor treatment. Therefore, we investigated whether GATA3 mutations predict the outcome of tamoxifen treatment in the advanced setting. In a retrospective study consisting of 235 hormone-naive patients with ER-positive breast cancer who received tamoxifen as first-line treatment for recurrent disease, GATA3 mutations (in 14.0% of patients) did not significantly associate with either the overall response rate (ORR) or with the length of progression-free survival (PFS) after the start of tamoxifen therapy. Interestingly, among 148 patients for whom both mutation and mRNA expression data were available, GATA3 mutations associated with an increased expression of GATA3. However, only 23.7% of GATA3 high tumors had a mutation. Evaluation of the clinical significance of GATA3 mRNA revealed that it was associated with prolonged PFS, but not with the ORR, also in multivariate analysis. Thus, GATA3 mRNA expression, but not GATA3 mutation, is an independent predictor of prolonged PFS in ER-positive breast cancer patients who received first-line tamoxifen for recurrent disease. Besides GATA3 mutation, other mechanisms must exist that underlie increased GATA3 levels.
The Molecular Genetics of Hypoparathyroidism
2015, The Parathyroids: Basic and Clinical Concepts: Third Edition
Non-surgical, inherited hypoparathyroidism consists of a group of heterogeneous disorders characterized by hypocalcemia and hyperphosphatemia resulting from inadequate PTH synthesis, secretion, or action. Hypoparathyroidism may present as the sole manifestation or in combination with additional features. Until 20 years ago they were mainly referred to as idiopathic hypoparathyroidism, since genetic tests were not available. In the last two decades, the molecular basis of many of the isolated and familial forms of the disease has been unraveled and accurate and targeted cytogenetic/genetic analyses are now available to better classify and consequently improve clinical management. In parallel, mouse models of the corresponding diseases have been generated, helping to define and dissect in vivo the newly identified molecular pathways. The identification of genes important for parathyroid development, differentiation and function and the steadily growing research in this field have shed light on new regulators of mineral metabolism.
Differential expression of GATA-3 in urothelial carcinoma variants
2014, Human Pathology
Citation Excerpt :
GATA-3 is a member of the GATA family of transcriptional factors, which can bind to the consensus DNA sequence G-A-T-A via zinc-finger domains [7]. GATA-3 is composed of 443 amino acids and has a molecular weight of 48 kd [8]. It was first identified as a T-cell–specific transcription factor involved in cell differentiation [9]; subsequent studies have found that GATA-3 plays an important role in embryogenesis of the breast, kidney, parathyroid glands, skin, urothelium, and adipose tissue [10-15].
GATA binding protein 3 (GATA-3) is a novel immunohistochemical marker for urothelial carcinoma (UC); however, few studies have investigated GATA-3's role as a marker for UC variants. We used immunohistochemistry to assess GATA-3 expression in different UC variants, including micropapillary (n = 46), sarcomatoid (n = 43), small cell carcinoma (n = 22), and plasmacytoid (n = 16) variants, and we also compared GATA-3 expression in conventional bladder UC (n = 103) to that in squamous cell carcinoma (n = 14). GATA-3 expression was present in 70% (72/103) of conventional bladder UCs and highly concordant between matched primary and metastatic UCs. The GATA-3 expression levels of the micropapillary variants (57%; 26/46) and plasmacytoid variants (44%; 7/16) were not significantly different from that of conventional UC. However, the GATA-3 expression levels of the sarcomatoid variants (16%; 7/43) and small cell carcinoma variants (5%; 1/22), which only weakly expressed the protein, were significantly lower than that of conventional UC (P < .001). Only 7% of squamous cell carcinomas (1/14) expressed GATA-3, and it was also significantly lower than that of conventional UC (P < .001). GATA-3 expression was not significantly associated with tumor stage or patients' clinical outcomes. In conclusion, GATA-3 expression differed among UC variants. GATA-3 is a useful marker for confirming the urothelial origin of micropapillary and plasmacytoid UC variants but not that of sarcomatoid or small cell carcinoma variants. GATA-3 can also be used in differentiating UC from squamous cell carcinoma.
Transcription factor GATA-3 in Atlantic salmon (Salmo salar): Molecular characterization, promoter activity and expression analysis
2009, Molecular Immunology
GATA-3 is a T cell-specific transcription factor and is essential for the development of the T cell lineage and differentiation of T helper type 2 cells. We have identified and characterized the full-length Atlantic salmon GATA-3 cDNA (3074 bp), having two zinc finger domains which are fully conserved within teleosts and higher vertebrates. RT-PCR analysis revealed that the Atlantic salmon GATA-3 (AsGATA-3) is strongly expressed in gills, thymus, and brain. Moreover, the involvement of GATA-3 in Atlantic salmon immune response was demonstrated by investigating the early time dependent expression profile of GATA-3 in spleen and head kidney following intraperitoneal injection of live Aeromonas salmonicida, LPS, and β-glucan. Furthermore, we have determined 1.9 kb of upstream promoter sequence and found a number of sequence motifs which match those of known transcription factor binding sites and the AsGATA-3 promoter is a TATA-less promoter. Activities of presumptive regulatory regions of this gene were assessed by transfecting different 5′ deletion constructs and the result showed the basal promoter and positive transcriptional regulator activity of AsGATA-3 gene is determined by sequences located between +58 and −199 bp upstream of the transcriptional start site (TSS). This study provides further insights into the transcriptional regulation of AsGATA-3.

View all citing articles on Scopus

View full text

Regular ArticleStructure and Expression of the Human GATA3 Gene

Abstract

Regular Article
Structure and Expression of the Human GATA3 Gene